1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014

Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014" provides data on the Low-Grade Astrocytoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Low-Grade Astrocytoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Low-Grade Astrocytoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Low-Grade Astrocytoma 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Low-Grade Astrocytoma to Oncology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by Phase 15
Clinical Trials by Trial Status 16
Clinical Trials by End Point Status 17
Unaccomplished Trials of Low-Grade Astrocytoma 18
Subjects Recruited Over a Period of Time 19
Clinical Trials by Sponsor Type 20
Prominent Sponsors 21
Prominent Drugs 22
Clinical Trial Profiles 23
Clinical Trial Overview of Top Companies 23
Burzynski Research Institute, Inc. 23
Clinical Trial Overview of Burzynski Research Institute, Inc. 23
Clinical Trial Overview of Top Institutes / Government 24
National Cancer Institute 24
Clinical Trial Overview of National Cancer Institute 24
City of Hope National Medical Center 25
Clinical Trial Overview of City of Hope National Medical Center 25
Memorial Sloan Kettering Cancer Center 26
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 26
UCLA's Jonsson Comprehensive Cancer Center 27
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center 27
Children's Oncology Group 28
Clinical Trial Overview of Children's Oncology Group 28
New York University School of Medicine 29
Clinical Trial Overview of New York University School of Medicine 29
Roswell Park Cancer Institute 30
Clinical Trial Overview of Roswell Park Cancer Institute 30
Five Key Clinical Profiles 31
Appendix 101
Abbreviations 101
Definitions 101
Research Methodology 102
Secondary Research 102
About GlobalData 103
Contact Us 103
Disclaimer 103
Source 104

List of Tables
Low-Grade Astrocytoma Therapeutics, Global, Clinical Trials by Region, 2014* 6
Low-Grade Astrocytoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Low-Grade Astrocytoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Low-Grade Astrocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Low-Grade Astrocytoma Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Low-Grade Astrocytoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Low-Grade Astrocytoma to Oncology Clinical Trials, G7 Countries (%), 2014* 12
Low-Grade Astrocytoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Low-Grade Astrocytoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Low-Grade Astrocytoma Therapeutics, Global, Clinical Trials by Phase, 2014* 15
Low-Grade Astrocytoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 16
Low-Grade Astrocytoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 17
Low-Grade Astrocytoma Therapeutics, Global, Suspended Clinical Trials, 2014* 18
Low-Grade Astrocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 19
Low-Grade Astrocytoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 20
Low-Grade Astrocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 21
Low-Grade Astrocytoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 22
Low-Grade Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Burzynski Research Institute, Inc., 2014* 23
Low-Grade Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 24
Low-Grade Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2014* 25
Low-Grade Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 26
Low-Grade Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2014* 27
Low-Grade Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014* 28
Low-Grade Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2014* 29
Low-Grade Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2014* 30

List of Figures
Low-Grade Astrocytoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Low-Grade Astrocytoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Low-Grade Astrocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Low-Grade Astrocytoma Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 10
Low-Grade Astrocytoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Low-Grade Astrocytoma to Oncology Clinical Trials, G7 Countries (%), 2014* 12
Low-Grade Astrocytoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Low-Grade Astrocytoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Low-Grade Astrocytoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 15
Low-Grade Astrocytoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 16
Low-Grade Astrocytoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 17
Low-Grade Astrocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 19
Low-Grade Astrocytoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 20
Low-Grade Astrocytoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 22
GlobalData Methodology 102

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Lung Cancer: Analytical Tool

Lung Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

Brain Cancer: Analytical Tool

August 2016 $ 8096

Breast Cancer: Analytical Tool

August 2016 $ 8096

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.